Corrigendum to“Nitrosamines crisis in pharmaceuticals-Insights on toxicological implications,root causes and risk assessment:A systematic review”[J.Pharm.Anal.14(2024)100919]  

作　　者：Hemanth P.R.Vikram Tegginamath Pramod Kumar Gunjan Kumar Narasimha M.Beeraka Rajashree Deka Sheik Mohammed Suhail Sandeep Jat Namitha Bannimath Gayatiri Padmanabhan Ravandur S.Chandan Pramod Kumar Bannimath Gurupadayya 

机构地区：[1]Department of Pharmaceutical Chemistry,JSS College of Pharmacy Mysuru,JSS Academy of Higher Education and Research(JSSAHER),Mysuru,570015,India [2]Xenone Healthcare Pvt.Ltd.,New Delhi,110076,India [3]Department of Pharmaceutics,JSS College of Pharmacy Mysuru,JSS Academy of Higher Education and Research(JSSAHER),Mysuru,570015,India [4]Department of Human Anatomy,I.M.Sechenov First Moscow State Medical University(Sechenov University),Moscow,119991,Russian Federation [5]Department of Pharmacology,Raghavendra Institute of Pharmaceutical Education and Research(RIPER),Ananthapuramu,515721,India [6]Herman B.Wells Center for Pediatric Research,Department of Pediatrics,Indiana University School of Medicine,Indianapolis,IN,46202,USA [7]Animal Physiology and Biochemistry Laboratory,Department of Zoology,Gauhati University,Guwahati,781014,India [8]Department of Pharmacology,JSS College of Pharmacy Mysuru,JSS Academy of Higher Education and Research(JSSAHER),Mysuru,570015,India [9]Department of Pharmaceutical Analysis,National Institute of Pharmaceutical Education and Research(NIPER)-Guwahati,Changsari,781101,India [10]Department of Pharmacology,University of Galway,Galway,H91 TK33,Ireland

出　　处：《Journal of Pharmaceutical Analysis》2024年第6期934-936,共3页药物分析学报（英文版）

摘　　要：Original statement in the Section 2:2.Literature search Our primary screening of 180 articles yielded the relevant data for this study.2.1.Study selection A total of 180 articles spanning from 1960 to the present day,including original research,reviews,case reports and studies reporting nitrosamine impurities above the no-observed-adverse-effect levels(NOAEL)established by regulatory agencies,were initially screened.During the primary screening,we considered factors such as relevance,publication date,access to the full article text,and content.

关 键 词：statement initially SPANNING 

分 类 号：R95[医药卫生—药学]